Skip to content

Author

S. Buchrits

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Oct 2026

Beyond disease control in chronic myeloid leukemia: Real-world quality of life across TKIs and treatment-free remission

Tyrosine kinase inhibitors (TKIs) have transformed chronic myeloid leukemia (CML) into a chronic condition with near-normal life expectancy. As patients remain on therapy for years, health-related quality of life (HRQoL) and patient-reported outcomes (PROs) are increasingly important in therapeutic decision-making. H...

S. Buchrits, Giora Sharf, P. Raanani et al. · 0 citations
Review Open access Aug 2026

Cardiac Adverse Events in Patients With Chronic Lymphocytic Leukemia Treated With First-Line Ibrutinib-Venetoclax.

BACKGROUND Fixed-duration combination of ibrutinib and venetoclax (IV) has emerged as a highly effective first-line treatment for chronic lymphocytic leukemia (CLL). However, the cardiac safety profile of this regimen has not been comprehensively characterized. We conducted a systematic review and meta-analysis to eval...

L. Hofstetter, S. Buchrits, A. Sherban et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.